Brief: Medovex says DenerveX device successfully completed its phase III testing
02/04/2015 14:02
April 2 (Reuters) - Medovex Corp MDVX.O : * Says co's DenerveX device has successfully completed its phase III design and development device testing * Source text for Eikon ID:nMKWKLVR0a * Further company coverage MDVX.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Innoveren Scientific
See all newsBrief: H-Cyte Announces Intent To Acquire Skindisc
Brief: Medovex Corp Announces Name Change To H-Cyte And New Ticker Symbol
Brief: Nasdaq Announces Delisting Of Certain Securities
Brief: Medovex files for non-timely 10-Q
Brief: Medovex Corp announced that it has launched its DenerveX System device in Spain with distributor Prim SA